Alnylam Pharmaceuticals, Inc. (ALNY) vs Revolution Medicines, Inc. (RVMD)

• Alnylam Pharmaceuticals, Inc. ALNY 231.83 ▼ −0.94%
• Revolution Medicines, Inc. RVMD 177.96 ▼ −5.97%

Alnylam Pharmaceuticals, Inc. and Revolution Medicines, Inc. are both Biotechnology companies. Revolution Medicines, Inc. is the larger, with a market value of $40.6B against $31.3B — 1.3× the size. Revolution Medicines, Inc. has negative trailing earnings, so its P/E is not meaningful; Alnylam Pharmaceuticals, Inc. trades at 39.5×. Alnylam Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 95.1% against −8.81%. Alnylam Pharmaceuticals, Inc. has the higher net margin (16.1% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Alnylam Pharmaceuticals, Inc. leads on 14 and Revolution Medicines, Inc. on 3.